137 related articles for article (PubMed ID: 16184606)
21. Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.
De Rooij KE; De Koning Gans PA; Skraastad MI; Belfroid RD; Vegter-Van Der Vlis M; Roos RA; Bakker E; Van Ommen GJ; Den Dunnen JT; Losekoot M
J Med Genet; 1993 Dec; 30(12):996-1002. PubMed ID: 8133511
[TBL] [Abstract][Full Text] [Related]
22. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
23. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
[TBL] [Abstract][Full Text] [Related]
24. Frailty and Associated Environmental Factors Only Have Small Effects on Age of Onset in Huntington's Disease.
Jeyakumar N; Hilmer SN; Teixeira-Pinto A; Loy CT
J Huntingtons Dis; 2023; 12(4):355-361. PubMed ID: 38007671
[TBL] [Abstract][Full Text] [Related]
25. A new drug design targeting the adenosinergic system for Huntington's disease.
Huang NK; Lin JH; Lin JT; Lin CI; Liu EM; Lin CJ; Chen WP; Shen YC; Chen HM; Chen JB; Lai HL; Yang CW; Chiang MC; Wu YS; Chang C; Chen JF; Fang JM; Lin YL; Chern Y
PLoS One; 2011; 6(6):e20934. PubMed ID: 21713039
[TBL] [Abstract][Full Text] [Related]
26. CAG repeat size and clinical presentation in Huntington's disease.
Ashizawa T; Wong LJ; Richards CS; Caskey CT; Jankovic J
Neurology; 1994 Jun; 44(6):1137-43. PubMed ID: 8208412
[TBL] [Abstract][Full Text] [Related]
27. Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
[TBL] [Abstract][Full Text] [Related]
28. Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.
Simpson SA; Davidson MJ; Barron LH
J Med Genet; 1993 Dec; 30(12):1014-7. PubMed ID: 8133498
[TBL] [Abstract][Full Text] [Related]
29. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
[TBL] [Abstract][Full Text] [Related]
30. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.
Swami M; Hendricks AE; Gillis T; Massood T; Mysore J; Myers RH; Wheeler VC
Hum Mol Genet; 2009 Aug; 18(16):3039-47. PubMed ID: 19465745
[TBL] [Abstract][Full Text] [Related]
31. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
32. [Study of the association of genotype and phenotype features of the pathogenesis of Huntington's chorea].
Hryshchenko NV; Kucherenko AM; Patskun EI; Livshyts' LA
Tsitol Genet; 2009; 43(3):42-7. PubMed ID: 19938636
[TBL] [Abstract][Full Text] [Related]
33. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease.
Milunsky JM; Maher TA; Loose BA; Darras BT; Ito M
Clin Genet; 2003 Jul; 64(1):70-3. PubMed ID: 12791042
[TBL] [Abstract][Full Text] [Related]
34. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
35. Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.
Taherzadeh-Fard E; Saft C; Wieczorek S; Epplen JT; Arning L
Neurogenetics; 2010 Oct; 11(4):435-9. PubMed ID: 20512606
[TBL] [Abstract][Full Text] [Related]
36. Huntington's disease like-2: review and update.
Margolis RL; Rudnicki DD; Holmes SE
Acta Neurol Taiwan; 2005 Mar; 14(1):1-8. PubMed ID: 15835282
[TBL] [Abstract][Full Text] [Related]
37. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
Martire A; Calamandrei G; Felici F; Scattoni ML; Lastoria G; Domenici MR; Tebano MT; Popoli P
Neurosci Lett; 2007 Apr; 417(1):78-83. PubMed ID: 17331645
[TBL] [Abstract][Full Text] [Related]
38. Linkage disequilibrium between the expanded (CAG)n repeat and an allele of the adjacent (CCG)n repeat in Huntington's disease patients of Greek origin.
Yapijakis C; Vassilopoulos D; Tzagournisakis M; Maris T; Fesdjian C; Papageorgiou C; Plaitakis A
Eur J Hum Genet; 1995; 3(4):228-34. PubMed ID: 8528671
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.
Klepac N; Relja M; Klepac R; Hećimović S; Babić T; Trkulja V
J Neurol; 2007 Dec; 254(12):1676-83. PubMed ID: 17990062
[TBL] [Abstract][Full Text] [Related]
40. The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington's Disease: A Historical Perspective.
Monckton DG
J Huntingtons Dis; 2021; 10(1):7-33. PubMed ID: 33579863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
